Log inSign up
Eduardo Zimmer
5,905 posts
Image
user avatar
Eduardo Zimmer
@erzimmer
Researcher @hospitalmoinhos | @ufrgsnoticias @zimmerneurolab | @mcgillu | @iserrapilheira | Interested in Glia and Neurodegeneration
Porto Alegre, Brasil
zimmer-lab.org
Joined October 2011
2,649
Following
3,923
Followers
  • Pinned
    user avatar
    Eduardo Zimmer
    @erzimmer
    Nov 9, 2025
    Our new paper just out in @NatureNeuro covered by @alzforum ๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡
    user avatar
    Alzforum
    @alzforum
    Nov 8, 2025
    Glia team up in #Alzheimersdisease: astrocyte reactivity rises with amyloid and tau, though only when riled-up microglia are in the mix. @mcgillu @ufrgsnoticias ow.ly/yqYu50XoLyT
    1.3K
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Feb 9, 2021
    Decidi montar meu laboratรณrio de pesquisa no ๐Ÿ‡ง๐Ÿ‡ท, mesmo tendo opรงรตes para trabalhar em qualquer lugar do๐ŸŒ! Contribuir para a formaรงรฃo da nova geraรงรฃo cientistas do paรญs รฉ a minha maior recompensa. Hoje em venho aqui te pedir para me ajudar a salvar a ciรชncia do๐Ÿ‡ง๐Ÿ‡ท! #cienciasalva +
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Nov 6, 2020
    O รบltimo medicamento aprovado para o tratamento da doenรงa de Alzheimer foi a "memantina" lรก em 2003. Os anos foram passando, e a comunidade acadรชmica da รกrea, apesar de ter evoluรญdo muito no entendimento da doenรงa, nรฃo conseguiu desenvolver um novo medicamento.
    Image
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Jun 7, 2021
    ALERTA DE NOVO MEDICAMENTO APROVADO PARA O ALZHEIMER. ๐Ÿšจ O #aducanumab acaba de ser aprovado pelo @US_FDA para o tratamento da doenรงa de #Alzheimer. Eu, o @wagnersbrum e o @jpfsouza33 resolvemos fazer um resumo dessa histรณria cheia de controvรฉrsias. Segue o ๐Ÿงถ 1/n
    Image
    GIF
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Oct 13, 2021
    I am delighted to receive the โ€˜One to Watchโ€™ Award๐Ÿ… from the @alzassociation! In such difficult times for doing research in ๐Ÿ‡ง๐Ÿ‡ท, it makes me confident that I am following the right pathway! But as I said at #AAICNeuro live session: It is all about team work! 1/1
    user avatar
    Alzheimer's Association
    @alzassociation
    Oct 13, 2021
    Congratulations to @ufrgsnoticias Assistant Professor @erzimmer, recipient of the #AAICNeuro โ€˜One to Watchโ€™ Award. Dr. Zimmerโ€™s laboratory @zimmerneurolab focuses on understanding the cellular origins of Alzheimer's disease, with a particular interest in astrocytes.
    Image
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Apr 6, 2022
    "Of all gray matter astrocytes, 99.8% are connected to at least one blood vessel" ๐Ÿ‘‰ sciencedirect.com/science/articlโ€ฆ! Very elegant work by #brunoweber group!
    Image
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Jan 29, 2022
    I finally received the "One-to-Watch award" trophy from #AAICnext in ๐Ÿ‡ง๐Ÿ‡ท and it is GORGEOUS! Thank you @DrMariaALZ @claire_e_sexton @HeatherAlz @stforner @percyg @ALZ_Rebecca @pgriffin315 and all @alzassociation members! A huge thanks to @zimmerneurolab students and collabs!๐Ÿ…๐Ÿง 
    Image
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Jul 21, 2023
    A new milestone ๐Ÿ‘‰ 100 papers on PubMed/MedLine! ๐Ÿ˜Š
    Image
    8.6K
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Oct 8, 2021
    A metade dos pesquisadores brasileiros se organizou em grupos para solicitar uma pequenina verba de pesquisa em um edital clรกssico chamado de "Universal". A outra metade estรก revisando os projetos submetidos. 1/n
    user avatar
    Folha de S.Paulo
    @folha
    Oct 8, 2021
    Congresso aprova corte de 92% de recursos da Ciรชncia a pedido do Ministรฉrio da Economia www1.folha.uol.com.br/ciencia/2021/1โ€ฆ
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Aug 30, 2021
    A huge thanks to the @alzassociation for funding our project. The @zimmerneurolab will be trying to discover novel astrocyte biomarkers in the early preclinical stages of #Alzheimers! Stay tuned for great science coming from ๐Ÿ‡ง๐Ÿ‡ท! @ppgbioq @ufrgsnoticias @ppgfarmaco @PropesqUfrgs
    Image
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Jul 16, 2023
    The NIA-AA Alzheimerโ€™s disease criteria update now include GFAP as a marker of reactive astrogliosis ๐Ÿ‘‡ #AAIC23 #astrocytes
    Image
    11K
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Mar 14, 2024
    If you believe, you're unstoppable! The work of @alzassociation is helping researchers in LMIC, like me, to be part of the scientific community and contribute to #ENDALZ ๐Ÿ’œ
    user avatar
    Alzheimer's Association
    @alzassociation
    Mar 14, 2024
    โ€œIf we believe we can change things, we can. Everyone told me it would be hard to do high-quality research in my home country of Brazil. I saw an opportunity to help people in lower-income countries. My lab now has 37 students.โ€ - @erzimmer, @ISTAART member, #ALZFunded
    Image
    9.1K
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Jul 18, 2023
    The @alzassociation is making a significant impact on dementia research in LMICs/UMICs, providing outstanding long-term funding opportunities! The @zimmerneurolab is funding by @alzassociation and it is committed to fight for a ๐ŸŒ without #alzheimers #ENDALZ
    Image
    3.2K
  • user avatar
    Eduardo Zimmer
    @erzimmer
    Feb 9, 2021
    Replying to @erzimmer
    Ajude a salvar a nossa principal fonte de financiamento clientรญfico e tecnolรณgico do Paรญs, o #FNDCT! Compartilhe e assine o abaixo-assinado que jรก tem + de 80.000 assinaturas: bit.ly/2YTULH8. Sem o financiamento do #FNDCT o๐Ÿ‡ง๐Ÿ‡ทnรฃo tem futuro. +
    131.646 pessoas assinaram e ajudaram esta petiรงรฃo a conseguir vitรณria
    131.646 pessoas assinaram e ajudaram esta petiรงรฃo a conseguir vitรณria
    From change.org

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|ยฉ 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement